z-logo
open-access-imgOpen Access
Phase I study of the gamma secretase inhibitor PF-03084014 in combination with docetaxel in patients with advanced triple-negative breast cancer
Author(s) -
M. Locatelli,
Philippe Aftimos,
Claire Dees,
Patricia LoRusso,
Mark D. Pegram,
Ahmad Awada,
Bo Huang,
Rossano Cesari,
Yuqiu Jiang,
M. Naveed Shaik,
Kenneth A. Kern,
Giuseppe Curigliano
Publication year - 2017
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/nc45-a394
Subject(s) - docetaxel , triple negative breast cancer , oncology , medicine , cancer , breast cancer , cancer research , triple negative

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here